7.30
0.16 (2.17%)
| Previous Close | 7.15 |
| Open | 7.25 |
| Volume | 2,228 |
| Avg. Volume (3M) | 16,193 |
| Market Cap | 53,292,964 |
| Price / Earnings (Forward) | 8.25 |
| Price / Sales | 1.32 |
| Price / Book | 0.800 |
| 52 Weeks Range | |
| Earnings Date | 14 May 2026 |
| Profit Margin | -159.80% |
| Operating Margin (TTM) | -139.35% |
| Diluted EPS (TTM) | -0.550 |
| Quarterly Revenue Growth (YOY) | 17.30% |
| Total Debt/Equity (MRQ) | 41.16% |
| Current Ratio (MRQ) | 2.01 |
| Operating Cash Flow (TTM) | -32.12 M |
| Levered Free Cash Flow (TTM) | -8.96 M |
| Return on Assets (TTM) | -24.04% |
| Return on Equity (TTM) | -59.05% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | DarioHealth Corp. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 19.69% |
| % Held by Institutions | 16.66% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |